ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Preimplantation Genetic Screening (PGS) Technology Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-24D5666
Home | Market Reports | Health| Reproductive Health
Global Preimplantation Genetic Screening PGS Technology Market Insights and Forecast to 2028
BUY CHAPTERS

Global Preimplantation Genetic Screening (PGS) Technology Market Research Report 2025

Code: QYRE-Auto-24D5666
Report
September 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Illumina Inc
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer Inc
CooperSurgical
Natera
Takara Bio
Oxford Gene Technology
Invicta
Genea Limited
Progenesis
IGENOMIX
Reproductive Health and Wellness Center

Preimplantation Genetic Screening (PGS) Technology Market

The global market for Preimplantation Genetic Screening (PGS) Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Preimplantation genetic screening (PGS) determines the chromosomal status of an embryo by screening all 23 chromosome pairs prior to transfer in an IVF cycle.
North American market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Preimplantation Genetic Screening (PGS) Technology in Maternity Centers & Fertility Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Preimplantation Genetic Screening (PGS) Technology include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Coopersurgical, Natera, Takara Bio, Oxford Gene Technology, INVICTA, Genea, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetic Screening (PGS) Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Screening (PGS) Technology.
The Preimplantation Genetic Screening (PGS) Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preimplantation Genetic Screening (PGS) Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preimplantation Genetic Screening (PGS) Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Preimplantation Genetic Screening (PGS) Technology Market Report

Report Metric Details
Report Name Preimplantation Genetic Screening (PGS) Technology Market
Segment by Type
  • Next-generation Sequencing
  • Polymerase Chain Reaction
  • Fluorescence in Situ Hybridization
  • Comparative Genomic Hybridization
  • Single-nucleotide Polymorphism
Segment by Application
  • Maternity Centers & Fertility Clinics
  • Hospitals
  • Research Laboratories & Academic Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Coopersurgical, Natera, Takara Bio, Oxford Gene Technology, INVICTA, Genea, Progenesis, Igenomix, Reproductive Health and Wellness Center
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Preimplantation Genetic Screening (PGS) Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Preimplantation Genetic Screening (PGS) Technology Market report?

Ans: The main players in the Preimplantation Genetic Screening (PGS) Technology Market are Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Coopersurgical, Natera, Takara Bio, Oxford Gene Technology, INVICTA, Genea, Progenesis, Igenomix, Reproductive Health and Wellness Center

What are the Application segmentation covered in the Preimplantation Genetic Screening (PGS) Technology Market report?

Ans: The Applications covered in the Preimplantation Genetic Screening (PGS) Technology Market report are Maternity Centers & Fertility Clinics, Hospitals, Research Laboratories & Academic Institutes, Others

What are the Type segmentation covered in the Preimplantation Genetic Screening (PGS) Technology Market report?

Ans: The Types covered in the Preimplantation Genetic Screening (PGS) Technology Market report are Next-generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Single-nucleotide Polymorphism

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Next-generation Sequencing
1.2.3 Polymerase Chain Reaction
1.2.4 Fluorescence in Situ Hybridization
1.2.5 Comparative Genomic Hybridization
1.2.6 Single-nucleotide Polymorphism
1.3 Market by Application
1.3.1 Global Preimplantation Genetic Screening (PGS) Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Maternity Centers & Fertility Clinics
1.3.3 Hospitals
1.3.4 Research Laboratories & Academic Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Perspective (2020-2031)
2.2 Global Preimplantation Genetic Screening (PGS) Technology Growth Trends by Region
2.2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Region (2020-2025)
2.2.3 Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Region (2026-2031)
2.3 Preimplantation Genetic Screening (PGS) Technology Market Dynamics
2.3.1 Preimplantation Genetic Screening (PGS) Technology Industry Trends
2.3.2 Preimplantation Genetic Screening (PGS) Technology Market Drivers
2.3.3 Preimplantation Genetic Screening (PGS) Technology Market Challenges
2.3.4 Preimplantation Genetic Screening (PGS) Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Revenue
3.1.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Revenue (2020-2025)
3.1.2 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Players (2020-2025)
3.2 Global Preimplantation Genetic Screening (PGS) Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Preimplantation Genetic Screening (PGS) Technology Revenue
3.4 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio
3.4.1 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Screening (PGS) Technology Revenue in 2024
3.5 Global Key Players of Preimplantation Genetic Screening (PGS) Technology Head office and Area Served
3.6 Global Key Players of Preimplantation Genetic Screening (PGS) Technology, Product and Application
3.7 Global Key Players of Preimplantation Genetic Screening (PGS) Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Type
4.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Type (2020-2025)
4.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Type (2026-2031)
5 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Application
5.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Application (2020-2025)
5.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size (2020-2031)
6.2 North America Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2020-2025)
6.4 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size (2020-2031)
7.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2020-2025)
7.4 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size (2020-2031)
8.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size (2020-2031)
9.2 Latin America Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2020-2025)
9.4 Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size (2020-2031)
10.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Preimplantation Genetic Screening (PGS) Technology Introduction
11.1.4 Illumina Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Introduction
11.2.4 Thermo Fisher Scientific Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Introduction
11.3.4 Agilent Technologies Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.3.5 Agilent Technologies Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Details
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Introduction
11.4.4 PerkinElmer Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.4.5 PerkinElmer Recent Development
11.5 Coopersurgical
11.5.1 Coopersurgical Company Details
11.5.2 Coopersurgical Business Overview
11.5.3 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Introduction
11.5.4 Coopersurgical Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.5.5 Coopersurgical Recent Development
11.6 Natera
11.6.1 Natera Company Details
11.6.2 Natera Business Overview
11.6.3 Natera Preimplantation Genetic Screening (PGS) Technology Introduction
11.6.4 Natera Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.6.5 Natera Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Preimplantation Genetic Screening (PGS) Technology Introduction
11.7.4 Takara Bio Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.7.5 Takara Bio Recent Development
11.8 Oxford Gene Technology
11.8.1 Oxford Gene Technology Company Details
11.8.2 Oxford Gene Technology Business Overview
11.8.3 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Introduction
11.8.4 Oxford Gene Technology Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.8.5 Oxford Gene Technology Recent Development
11.9 INVICTA
11.9.1 INVICTA Company Details
11.9.2 INVICTA Business Overview
11.9.3 INVICTA Preimplantation Genetic Screening (PGS) Technology Introduction
11.9.4 INVICTA Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.9.5 INVICTA Recent Development
11.10 Genea
11.10.1 Genea Company Details
11.10.2 Genea Business Overview
11.10.3 Genea Preimplantation Genetic Screening (PGS) Technology Introduction
11.10.4 Genea Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.10.5 Genea Recent Development
11.11 Progenesis
11.11.1 Progenesis Company Details
11.11.2 Progenesis Business Overview
11.11.3 Progenesis Preimplantation Genetic Screening (PGS) Technology Introduction
11.11.4 Progenesis Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.11.5 Progenesis Recent Development
11.12 Igenomix
11.12.1 Igenomix Company Details
11.12.2 Igenomix Business Overview
11.12.3 Igenomix Preimplantation Genetic Screening (PGS) Technology Introduction
11.12.4 Igenomix Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.12.5 Igenomix Recent Development
11.13 Reproductive Health and Wellness Center
11.13.1 Reproductive Health and Wellness Center Company Details
11.13.2 Reproductive Health and Wellness Center Business Overview
11.13.3 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Introduction
11.13.4 Reproductive Health and Wellness Center Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
11.13.5 Reproductive Health and Wellness Center Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Illumina Inc
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer Inc
CooperSurgical
Natera
Takara Bio
Oxford Gene Technology
Invicta
Genea Limited
Progenesis
IGENOMIX
Reproductive Health and Wellness Center
List of Tables
 Table 1. Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Next-generation Sequencing
 Table 3. Key Players of Polymerase Chain Reaction
 Table 4. Key Players of Fluorescence in Situ Hybridization
 Table 5. Key Players of Comparative Genomic Hybridization
 Table 6. Key Players of Single-nucleotide Polymorphism
 Table 7. Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Region (2020-2025)
 Table 11. Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Region (2026-2031)
 Table 13. Preimplantation Genetic Screening (PGS) Technology Market Trends
 Table 14. Preimplantation Genetic Screening (PGS) Technology Market Drivers
 Table 15. Preimplantation Genetic Screening (PGS) Technology Market Challenges
 Table 16. Preimplantation Genetic Screening (PGS) Technology Market Restraints
 Table 17. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Players (2020-2025)
 Table 19. Global Top Preimplantation Genetic Screening (PGS) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Screening (PGS) Technology as of 2024)
 Table 20. Ranking of Global Top Preimplantation Genetic Screening (PGS) Technology Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Preimplantation Genetic Screening (PGS) Technology Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Preimplantation Genetic Screening (PGS) Technology, Headquarters and Area Served
 Table 23. Global Key Players of Preimplantation Genetic Screening (PGS) Technology, Product and Application
 Table 24. Global Key Players of Preimplantation Genetic Screening (PGS) Technology, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type (2020-2025)
 Table 28. Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type (2026-2031)
 Table 30. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2020-2025)
 Table 32. Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2026-2031)
 Table 34. North America Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Illumina Company Details
 Table 50. Illumina Business Overview
 Table 51. Illumina Preimplantation Genetic Screening (PGS) Technology Product
 Table 52. Illumina Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 53. Illumina Recent Development
 Table 54. Thermo Fisher Scientific Company Details
 Table 55. Thermo Fisher Scientific Business Overview
 Table 56. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product
 Table 57. Thermo Fisher Scientific Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 58. Thermo Fisher Scientific Recent Development
 Table 59. Agilent Technologies Company Details
 Table 60. Agilent Technologies Business Overview
 Table 61. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product
 Table 62. Agilent Technologies Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 63. Agilent Technologies Recent Development
 Table 64. PerkinElmer Company Details
 Table 65. PerkinElmer Business Overview
 Table 66. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product
 Table 67. PerkinElmer Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 68. PerkinElmer Recent Development
 Table 69. Coopersurgical Company Details
 Table 70. Coopersurgical Business Overview
 Table 71. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product
 Table 72. Coopersurgical Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 73. Coopersurgical Recent Development
 Table 74. Natera Company Details
 Table 75. Natera Business Overview
 Table 76. Natera Preimplantation Genetic Screening (PGS) Technology Product
 Table 77. Natera Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 78. Natera Recent Development
 Table 79. Takara Bio Company Details
 Table 80. Takara Bio Business Overview
 Table 81. Takara Bio Preimplantation Genetic Screening (PGS) Technology Product
 Table 82. Takara Bio Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 83. Takara Bio Recent Development
 Table 84. Oxford Gene Technology Company Details
 Table 85. Oxford Gene Technology Business Overview
 Table 86. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Product
 Table 87. Oxford Gene Technology Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 88. Oxford Gene Technology Recent Development
 Table 89. INVICTA Company Details
 Table 90. INVICTA Business Overview
 Table 91. INVICTA Preimplantation Genetic Screening (PGS) Technology Product
 Table 92. INVICTA Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 93. INVICTA Recent Development
 Table 94. Genea Company Details
 Table 95. Genea Business Overview
 Table 96. Genea Preimplantation Genetic Screening (PGS) Technology Product
 Table 97. Genea Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 98. Genea Recent Development
 Table 99. Progenesis Company Details
 Table 100. Progenesis Business Overview
 Table 101. Progenesis Preimplantation Genetic Screening (PGS) Technology Product
 Table 102. Progenesis Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 103. Progenesis Recent Development
 Table 104. Igenomix Company Details
 Table 105. Igenomix Business Overview
 Table 106. Igenomix Preimplantation Genetic Screening (PGS) Technology Product
 Table 107. Igenomix Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 108. Igenomix Recent Development
 Table 109. Reproductive Health and Wellness Center Company Details
 Table 110. Reproductive Health and Wellness Center Business Overview
 Table 111. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product
 Table 112. Reproductive Health and Wellness Center Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025) & (US$ Million)
 Table 113. Reproductive Health and Wellness Center Recent Development
 Table 114. Research Programs/Design for This Report
 Table 115. Key Data Information from Secondary Sources
 Table 116. Key Data Information from Primary Sources
 Table 117. Authors List of This Report


List of Figures
 Figure 1. Preimplantation Genetic Screening (PGS) Technology Picture
 Figure 2. Global Preimplantation Genetic Screening (PGS) Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Type: 2024 VS 2031
 Figure 4. Next-generation Sequencing Features
 Figure 5. Polymerase Chain Reaction Features
 Figure 6. Fluorescence in Situ Hybridization Features
 Figure 7. Comparative Genomic Hybridization Features
 Figure 8. Single-nucleotide Polymorphism Features
 Figure 9. Global Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Application: 2024 VS 2031
 Figure 11. Maternity Centers & Fertility Clinics Case Studies
 Figure 12. Hospitals Case Studies
 Figure 13. Research Laboratories & Academic Institutes Case Studies
 Figure 14. Others Case Studies
 Figure 15. Preimplantation Genetic Screening (PGS) Technology Report Years Considered
 Figure 16. Global Preimplantation Genetic Screening (PGS) Technology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Preimplantation Genetic Screening (PGS) Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Region: 2024 VS 2031
 Figure 19. Global Preimplantation Genetic Screening (PGS) Technology Market Share by Players in 2024
 Figure 20. Global Top Preimplantation Genetic Screening (PGS) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Screening (PGS) Technology as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Preimplantation Genetic Screening (PGS) Technology Revenue in 2024
 Figure 22. North America Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2020-2031)
 Figure 24. United States Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2020-2031)
 Figure 28. Germany Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Share by Region (2020-2031)
 Figure 36. China Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2020-2031)
 Figure 44. Mexico Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Share by Country (2020-2031)
 Figure 48. Turkey Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Preimplantation Genetic Screening (PGS) Technology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Illumina Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 53. Agilent Technologies Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 54. PerkinElmer Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 55. Coopersurgical Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 56. Natera Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 57. Takara Bio Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 58. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 59. INVICTA Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 60. Genea Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 61. Progenesis Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 62. Igenomix Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 63. Reproductive Health and Wellness Center Revenue Growth Rate in Preimplantation Genetic Screening (PGS) Technology Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Preimplantation genetic testing market
Global Preimplantation Genetic Diagnostics PGD Market Research Report 2024
Global Preimplantation Genetic Screening Market Research Report 2025
Global Preimplantation Genetic Diagnosis Market Insights Forecast to 2030
Global Pre Implantation Genetic Diagnosis PGD Market Insights Forecast to 2030
Global Prenatal Genetic Screening Test Market Research Report 2024
Global Preimplantation Genetic Testing for Aneuploidy Kits Market Research Report 2025
Preimplantation Genetic Diagnosis PGD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vitro Fertilization Test Market Research Report 2024
Global Non invasive Preimplantation Genetic Testing Market Research Report 2024
Global Prenatal Genetic Screening Services Market Research Report 2025
Global Preimplantation Genetic Testing for Monogenic Single Gene Defects Kits Market Research Report 2025
Global Reproductive Genetics Reagents Market Research Report 2024
Global Embryo Biopsy Medium Market Research Report 2025
Global Embryo Selection Tool Market Research Report 2025
Global Antenatal Screening Market Research Report 2024
Pre marital and Pre Pregnancy Genetic Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Newborn Screening and Genetic Services Market Research Report 2024
Global Embryo Decision Support Tools Market Research Report 2025
Global Animal Genetic Testing Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions